Induction of diplochromosomes in mammalian cells by inhibitors of topoisomerase II

被引:36
|
作者
Sumner, AT [1 ]
机构
[1] MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland
关键词
D O I
10.1007/s004120050333
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diplochromosomes, consisting of four chromatids lying side-by-side, instead of the normal two, are produced when cells go through two rounds of DNA replication without separation of chromatids. They are thus an indication of the failure of the normal chromosome separation mechanism. In the present experiments, induction of diplochromosomes by inhibitors of topoisomerase II (Topo II) was used to provide further evidence that Topo LI is required for separation of daughter chromosomes. Actively growing cultures of CHO cells were treated with Colcemid, and separated into metaphase and interphase fractions, each of which was treated for 2 h with the Topo II inhibitor being tested. The cells were then cultivated in fresh medium without inhibitor for periods of between 18 and 44 h, and metaphase cells once again accumulated by treatment with Colcemid. Chromosome preparations were made in the standard way and stained with Giemsa. Up to 2,000 metaphases were counted from each culture, and the proportion with diplochromosomes calculated. At appropriate concentrations, the Topo II inhibitors etoposide and mitoxantrone induced substantial levels of metaphases with diplochromosomes in cultures that had been treated when the cells were in interphase (up to 30% and 11%, respectively). Amsacrine, however, only produced a smaller proportion (4.7%) of metaphases with diplochromosomes after a much longer culture period following treatment. All the inhibitors caused severe chromosome damage. When used to treat metaphase cells, mitoxantrone and amsacrine only induced diplochromosomes after prolonged culture, although a small number of diplochromosomes were seen after etoposide treatment and a shorter period of culture. Results with cells treated in metaphase might indicate that Topo II is, in fact, not required for anaphase chromosome separation, although it is clearly important for segregation of newly replicated DNA.
引用
收藏
页码:486 / 490
页数:5
相关论文
共 50 条
  • [41] Inhibition of topoisomerase II by the marine alkaloid ascididemin and induction of apoptosis in leukemia cells
    Dassonneville, L
    Wattez, N
    Baldeyrou, B
    Mahieu, C
    Lansiaux, A
    Banaigs, B
    Bonnard, I
    Bailly, C
    BIOCHEMICAL PHARMACOLOGY, 2000, 60 (04) : 527 - 537
  • [42] Topoisomerase II inhibitors affect entry into mitosis and chromosome condensation in BHK cells
    Anderson, H
    Roberge, M
    CELL GROWTH & DIFFERENTIATION, 1996, 7 (01): : 83 - 90
  • [43] TOPOISOMERASE-II ACTIVITY AND SENSITIVITY TO TOPOISOMERASE-II INHIBITORS ARE ALTERED IN NITROGEN MUSTARD-RESISTANT HUMAN-CELLS
    MATTERN, MR
    TAN, KB
    HERTZBERG, RP
    BOYCE, R
    MONG, SM
    CARANFA, MJ
    ZIMMERMAN, JP
    MIRABELLI, CK
    JOHNSON, RK
    CROOKE, ST
    SCHEIN, PS
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 278 - 278
  • [44] TOPOISOMERASE ACTIVITY IN IRRADIATED MAMMALIAN-CELLS
    WARTERS, RL
    LYONS, BW
    KENNEDY, K
    LI, TM
    MUTATION RESEARCH, 1989, 216 (01): : 43 - 55
  • [45] CLEAVAGE OF DNA BY MAMMALIAN DNA TOPOISOMERASE-II
    LIU, LF
    ROWE, TC
    YANG, L
    TEWEY, KM
    CHEN, GL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1983, 258 (24) : 5365 - 5370
  • [46] INDUCTION OF MAMMALIAN DNA TOPOISOMERASE-I AND TOPOISOMERASE-II MEDIATED DNA CLEAVAGE BY SAINTOPIN, A NEW ANTITUMOR AGENT FROM FUNGUS
    YAMASHITA, Y
    KAWADA, SZ
    FUJII, N
    NAKANO, H
    BIOCHEMISTRY, 1991, 30 (24) : 5838 - 5845
  • [47] Catalytic topoisomerase II inhibitors in cancer therapy
    Larsen, AK
    Eseargueil, AE
    Skladanowski, A
    PHARMACOLOGY & THERAPEUTICS, 2003, 99 (02) : 167 - 181
  • [48] Topoisomerase I and II Inhibitors: A Patent Review
    Singh, Arshdeep
    Kaur, Navdeep
    Singh, Gurpreet
    Sharma, Pooja
    Bedi, P. M. S.
    Sharma, Sahil
    Nepali, Kunal
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2016, 11 (04) : 401 - 423
  • [49] Azacyanines as Novel Topoisomerase II Alpha Inhibitors
    Guloglu, Sercan
    Kirmaci, Fahriye Nur
    Cetinkol, Ozgul Persil
    Forough, Mehrdad
    Gulkaya, Aybuke
    LETTERS IN DRUG DESIGN & DISCOVERY, 2020, 17 (05) : 666 - 671
  • [50] Acridine derivatives as inhibitors/poisons of topoisomerase II
    Kozurkova, Maria
    JOURNAL OF APPLIED TOXICOLOGY, 2022, 42 (04) : 544 - 552